跳至主要内容
临床试验/CTRI/2021/04/033175
CTRI/2021/04/033175进行中(未招募)3 期

A randomised controlled trial of oxygen delivery through nasal cannula or NIP masks in patients with confirmed COVID 19 infection: The PROVE Trial - PROVE

George Institute for Global Health India0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age >= 18 years
  • 2. Laboratory confirmed COVID-19 positive infection
  • 3. Requiring more than 40% oxygen (FiO2 > 0.4) â?? (requiring 6L or more of oxygen by Hudson mask
  • or nasal cannula) to maintain SpO2 >93%

排除标准

  • 1. Obtunded
  • 2. The attending clinician is not committed to patient receiving mechanical ventilatory support
  • 3. In the opinion of the treating clinician the patient is in respiratory distress and is eminently
  • requiring escalation of treatment including intubation and mechanical ventilation
  • 4. Currently receiving either CPAP, BiPAP, high flow nasal prongs or mechanical ventilation
  • 5. Participants usually on home ventilation (either CPAP or BiPAP)
  • 6. Previous participation in PROVE trial
  • 7. Known or suspected pregnancy
  • 8. Enrolment in the study is not in the best interest of the patient as deemed by the treating clinician

研究者

发起方
George Institute for Global Health India

相似试验